Biophytis Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Net Income	-17.03	-17.03	-24.22	-31.16	-25.52	-18.95	Upgrade
Depreciation & Amortization	0.8	0.8	0.48	0.31	0.28	0.26	Upgrade
Share-Based Compensation	0.81	0.81	5.57	3.42	0.79	0.06	Upgrade
Other Operating Activities	2.54	2.54	-0.82	3.64	14.71	3.57	Upgrade
Operating Cash Flow	-12.87	-12.87	-18.99	-23.8	-9.74	-15.05	Upgrade
Capital Expenditures	-0.22	-0.22	-0.14	-0.34	-0.21	-0.28	Upgrade
Change in Investments	0.59	0.59	0.12	12.5	-12.5	0	Upgrade
Investing Cash Flow	0.37	0.37	-0.02	12.16	-12.71	-0.28	Upgrade
Share Issuance / Repurchase	4.24	4.24	0	14.49	19.99	0	Upgrade
Debt Issued / Paid	0.64	0.64	4.92	17.07	0.8	7.58	Upgrade
Other Financing Activities	2.15	2.15	1.21	-1.84	1.17	-0.3	Upgrade
Financing Cash Flow	7.03	7.03	6.13	29.72	21.95	7.28	Upgrade
Exchange Rate Effect	-0.01	-0.01	-0	-0	0.01	-0.02	Upgrade
Net Cash Flow	-5.49	-5.49	-12.87	18.08	-0.49	-8.07	Upgrade
Free Cash Flow	-13.09	-13.09	-19.13	-24.14	-9.96	-15.33	Upgrade
Free Cash Flow Per Share	-96.44	-96.44	-437.64	-816.32	-664.08	-3632.84	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).